Market Update (NYSE:STJ): SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

[Business Wire] – St. Jude Medical, Inc. , a global medical device company, today announced results from the SHIELD I study that confirm the benefits of the HeartMate PHP™ cardiac assist device for . . . → Read More: Market Update (NYSE:STJ): SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures Similar Articles: Company Update (NYSE:STJ): St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System Stock Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical Expands Portfolio of MRI-Compatible Devices to High Voltage in Europe Stock Update (NYSE:STJ): St. Jude Medical Completes Acquisition of Spinal Modulation, Inc.